Abstract: The present invention provides a screening assay for identifying inhibitors of Pseudomonas aeruginosa CFTR Inhibitory Factor as well as compositions and methods for ameliorating or treating a respiratory disease such as cystic fibrosis or secondary infection thereof.
Type:
Grant
Filed:
December 29, 2015
Date of Patent:
June 18, 2019
Assignees:
TRUSTEES OF DARTMOUTH COLLEGE, THE REGENTS OF TE UNIVERSITY OF CALIFORNIA
Inventors:
Dean R. Madden, Christopher D. Bahl, Bruce D. Hammock, Christophe Morisseau
Abstract: The present invention provides a family of non-naturally occurring polypeptides having cholesterol efflux activity that parallels that of full-length apolipoproteins (e.g., Apo AI and Apo E), and having high selectivity for ABAC1 that parallels that of full-length apolipoproteins. The invention also provides compositions comprising such polypeptides, methods of identifying, screening and synthesizing such polypeptides, and methods of treating, preventing or diagnosing diseases and disorders associated with dyslipidemia, hypercholesterolemia and inflammation.
Type:
Application
Filed:
December 13, 2007
Publication date:
December 27, 2012
Applicant:
The Regents of te University of California